Oppenheimer & Co’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,440
Closed -$223K 1381
2017
Q3
$223K Buy
+5,440
New +$223K 0.01% 1149
2017
Q1
Sell
-10,957
Closed -$549K 1370
2016
Q4
$549K Sell
10,957
-453
-4% -$22.7K 0.02% 778
2016
Q3
$599K Sell
11,410
-215
-2% -$11.3K 0.02% 747
2016
Q2
$481K Sell
11,625
-1,352
-10% -$55.9K 0.01% 805
2016
Q1
$527K Sell
12,977
-6,495
-33% -$264K 0.02% 733
2015
Q4
$808K Sell
19,472
-30,482
-61% -$1.26M 0.02% 623
2015
Q3
$769K Buy
49,954
+6,451
+15% +$99.3K 0.02% 665
2015
Q2
$1.08M Buy
+43,503
New +$1.08M 0.03% 603